Progenity Inc (PROG)

$1.24 0.09 (6.77%)
16:00 EST PROG Stock Quote Delayed 30 Minutes

Progenity Stock’s Hype Cycle Is Over, It Needs Results

Progenity spent 2021 reinventing itself, dumping its testing laboratory, hiring a new CEO, and refocusing on its patent portfolio. PROG stock hopes its patent portfolio can result in new tests and treatments for disease, but mining it will take time and money.

PROG Stock Is a Buy As Progenity Becomes a Leaner Company

Progenity is Still a Sell as Company Lacks Catalysts

Progenity Is Unlikely to Live Up to Its IPO Hype

More Articles
Select Price, Percent change, or Dollar change as the y-axis.
Select Area, Line, OHLC or Candlestick as the chart type.
Previous Close -
Market Cap 203.05M
PE Ratio -0.33
EPS -3.78
Volume (Avg. Vol.) 11.54M
Day's Range $1.23 - $1.36
52-Week Range $0.66 - $7.86
Dividend & Yield N/A (N/A)